3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Wilson Disease: new trials by email Literature Review of Wilson Disease trials Research Report on Wilson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants ALXN1840, Bupropion Hydrochloride - Wilson Disease | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 54 | 2020-10-21 | 2023-08-31 |
| Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants. ALXN1840, Celecoxib - Wilson Disease | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 36 | 2020-07-07 | 2023-08-21 |
| Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants ALXN1840 - Wilson Disease | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 24 | 2019-02-20 | 2023-11-07 |
Hepatolenticular Degeneration (3)
Basal Ganglia Diseases (3) · Brain Diseases (3) · Brain Diseases, Metabolic (3) · Brain Diseases, Metabolic, Inborn (3) · Central Nervous System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Digestive System Diseases (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Liver Diseases (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Metal Metabolism, Inborn Errors (3) · Movement Disorders (3) · Nervous System Diseases (3)
tetrathiomolybdate (2) · Bupropion (1) · Celecoxib (1)
Alexion Pharmaceuticals, Inc. (3)
United States (2) · United Kingdom (1)
2018 (1)